Cargando…
Persistence on HIV preexposure prophylaxis medication over a 2‐year period among a national sample of 7148 PrEP users, United States, 2015 to 2017
INTRODUCTION: Persistence on preexposure prophylaxis for HIV prevention (PrEP) medication has rarely been reported for periods greater than one year, or in real‐world settings. This study used pharmacy fill records for PrEP users from a national chain pharmacy to describe persistence on PrEP medicat...
Autores principales: | Coy, Kelsey C, Hazen, Ronald J, Kirkham, Heather S, Delpino, Ambrose, Siegler, Aaron J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378757/ https://www.ncbi.nlm.nih.gov/pubmed/30775846 http://dx.doi.org/10.1002/jia2.25252 |
Ejemplares similares
-
Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for Injecting Drug Users
por: Smith, Dawn K., et al.
Publicado: (2013) -
Missed Visits Associated With Future Preexposure Prophylaxis (PrEP) Discontinuation Among PrEP Users in a Municipal Primary Care Health Network
por: Spinelli, Matthew A, et al.
Publicado: (2019) -
Optimizing Provider Preexposure Prophylaxis (PrEP) Training: A Cross-Sectional Analysis of Recommendations from Providers Across the PrEP Implementation Cascade
por: Rao, Sharanya, et al.
Publicado: (2021) -
The Ethical Relevance of “Alternatives” in Health Care Priority
Setting – The Case of Preexposure Prophylaxis (PrEP) of HIV
por: Gustavsson, Erik, et al.
Publicado: (2022) -
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort
por: Nozza, Silvia, et al.
Publicado: (2022)